Alible Pharmaceutical Private Limited

Alible Pharmaceutical Private Limited - pharma in Thane, Maharashtra, India. Directors, charges & compliance details.
CIN U24290MH2021PTC365379 Incorporated 05 August 2021 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2025
₹11.22 Lakh
▲ 10% YoY
Net loss · FY 2025
₹38,254
Net margin -3.4%
EBITDA · FY 2025
-₹34,574
EBITDA margin -3.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Alible Pharmaceutical Private Limited

Data last updated:

Alible Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 August 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC365379.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shivaji Ramesh Zodage (Managing Director) and Dilip Bajarang Shinde.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D/5 Ashtavinayak Chs Plot No 4 Panchpakhadi Savarkar Nagar, Thane, Maharashtra, India – 400606.

As per the financials filed for FY 2025, the company reported a revenue of ₹11.22 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net loss of ₹38,254 (net margin -3.4%) and EBITDA of -₹34,574 (EBITDA margin -3.1%). Revenue has grown at a compounded annual rate (CAGR) of 210% over three years.

Company details

CIN U24290MH2021PTC365379
Registration Number 365379
Incorporation Date 05 August 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active

Contact details

Alible Pharmaceutical Private Limited's registered office is in Thane, Maharashtra.

  • Registered Address
    D/5 Ashtavinayak Chs Plot No 4 Panchpakhadi Savarkar Nagar, Thane, Maharashtra, India – 400606
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Alible Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Alible Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Alible Pharmaceutical Private Limited, buy the company report.

Financials of Alible Pharmaceutical Private Limited

FY 2025 filings available

Alible Pharmaceutical Private Limited reported revenue of ₹11.22 Lakh (up 10% YoY) for FY 2025.

Revenue · FY 2025
₹11.22 Lakh ▲ 10%
Net loss · FY 2025
₹38,254 margin -3.4%
EBITDA · FY 2025
-₹34,574 margin -3.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 210%
EBITDA CAGR growth
1 year
▼ 155%
3 years · compounded
▼ 27%

Revenue has grown at a compounded annual rate (CAGR) of 210% over three years, including 10% growth in the latest year. EBITDA fell 155% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹34,574
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹38,254
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-3.1%
Net Profit Margin-3.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Alible Pharmaceutical Private Limited, buy the company report.

Board of directors of Alible Pharmaceutical Private Limited

Alible Pharmaceutical has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Dilip Bajarang ShindeDirector05 Aug 20215 Years 3 MonthsCurrent
Shivaji Ramesh ZodageManaging Director05 Aug 20215 Years 3 MonthsCurrent

Peer comparison

Alible Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Abvita Pharmaceuticals Private Limited₹11.28 Lakh (FY 2023)-73.0%Hyderabad, Telangana, India
Mohini Hygiene Care Products Private Limited₹11.25 Lakh (FY 2025)-92.0%Pithampur, Madhya Pradesh, India
Brit Allvin Pharmaceautical Private Limited₹11.25 Lakh (FY 2024)18.0%Karnal, Haryana, India
Tejika Labs Private Limited₹11.25 Lakh (FY 2023)46.0%Ankleshwar, Gujarat, India
Resalutem Pharmaceutical Private Limited₹11.22 Lakh (FY 2020)184.0%Surat, Gujarat, India
Alible Pharmaceutical Private Limitedthis company₹11.22 Lakh (FY 2025)-₹38,254-3.4%10.0%Thane, Maharashtra, India
Mahija Biofuel Industries Private Limited₹11.21 Lakh (FY 2023)Ahmedabad, Gujarat, India
Ignis Control Systems Private Limited₹11.2 Lakh (FY 2022)254.0%Bangalore, Karnataka, India
Swabhi Pharma Private Limited₹11.2 Lakh (FY 2022)64.0%Delhi, India
Ashoka Biotech Private Limited₹11.18 Lakh (FY 2023)107536250.0%Bangalore, Karnataka, India
Arm Bioorganic Private Limited₹11.18 Lakh (FY 2019)154.0%Vadodara, Gujarat, India

To see the full peer comparison of Alible Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Alible Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Alible Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Alible Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Dilip Bajarang Shinde was appointed as Director on 05 Aug 2021.

AGM
Alible Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Alible Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Dilip Bajarang Shinde was appointed as Director.
Appointed
Shivaji Ramesh Zodage was appointed as Managing Director.
Incorporation
05 Aug 2021
Alible Pharmaceutical Private Limited was registered on 05 Aug 2021 with Roc Mumbai Ii & aged 5 years 3 months as per MCA records.

Frequently asked questions

Alible Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 August 2021 (5+ years old) and is registered under CIN U24290MH2021PTC365379.

Alible Pharmaceutical has 2 current directors:

The latest financial statements of Alible Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Alible Pharmaceutical is U24290MH2021PTC365379. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Alible Pharmaceutical was incorporated on 05 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Alible Pharmaceutical by revenue are Abvita Pharmaceuticals Private Limited, Mohini Hygiene Care Products Private Limited, Brit Allvin Pharmaceautical Private Limited, Tejika Labs Private Limited, Resalutem Pharmaceutical Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Dilip Bajarang Shinde was appointed as Director on 05 Aug 2021. Shivaji Ramesh Zodage was appointed as Managing Director on 05 Aug 2021.

The registered office of Alible Pharmaceutical is at D5 Ashtavinayak Chs Plot No 4 Panchpakhadi Savarkar Nagar, Thane, Maharashtra, India – 400606.

Alible Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.

Alible Pharmaceutical can be reached at its registered office: D5 Ashtavinayak Chs Plot No 4 Panchpakhadi Savarkar Nagar, Thane, Maharashtra, India – 400606.

Alible Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.